MLchartDataset catalogue

Dexrazoxane

Term · Oncology and biomedicine · MLC-T-ONC-013013

A bisdioxopiperazine with iron-chelating, chemoprotective, cardioprotective, and antineoplastic activities. After hydrolysis to an active form that is similar to ethylenediaminetetraacetic acid (EDTA), dexrazoxane chelates iron, limiting the formation of free radical-generating anthracycline-iron complexes, which may minimize anthracycline-iron complex-mediated oxidative damage to cardiac and soft tissues. This agent also inhibits the catalytic activity of topoisomerase II, which may result in tumor cell growth inhibition.

Table 1. Record
IdentifierMLC-T-ONC-013013
FieldOncology and biomedicine
Synonymsrazoxane (+)-form
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013013",
  "term": "Dexrazoxane",
  "field": "Oncology and biomedicine",
  "definition": "A bisdioxopiperazine with iron-chelating, chemoprotective, cardioprotective, and antineoplastic activities. After hydrolysis to an active form that is similar to ethylenediaminetetraacetic acid (EDTA), dexrazoxane chelates iron, limiting the formation of free radical-generating anthracycline-iron complexes, which may minimize anthracycline-iron complex-mediated oxidative damage to cardiac and soft tissues. This agent also inhibits the catalytic activity of topoisomerase II, which may result in tumor cell growth inhibition.",
  "synonyms": [
    "razoxane (+)-form"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dexrazoxane/"
}

Record 5,897 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.